67 results
DEFA14A
APLS
Apellis Pharmaceuticals Inc
26 Apr 24
Additional proxy soliciting materials
4:08pm
. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained … in the box above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2024 BetaNXT, Inc. or its
8-K
EX-99.1
APLS
Apellis Pharmaceuticals Inc
27 Feb 24
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7:30am
to discuss its fourth quarter and year end 2023 financial results and business highlights today, February 27, 2024, at 8:30 a.m. ET. To access the live
8-K
EX-1.1
5q4p42i
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
8-K
EX-99.1
ya1m7z8b
31 Jul 23
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
8:03am
DEFA14A
w0apubd9274uh5z
21 Apr 23
Additional proxy soliciting materials
9:03am
8-K
EX-10.1
wa7meg4a u6n
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
hriw4o4
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
DEFA14A
bquh0m21iqz6gg9io
20 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
EX-1.1
uwfzrsict9ab6kinf2qx
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
8-K
EX-1.1
xv6yuf9u70a
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
30bsqt7es
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am